— Know what they know.
Not Investment Advice

NVOS OTC

Novo Integrated Sciences, Inc.
1W: -84.6% 1M: +0.0% 3M: -82.9% YTD: -77.8% 1Y: -88.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 52 · $11838 mcap · 18M float · 0.039% daily turnover · Short 43% of daily vol

Balance Sheet Trends

Total Assets
$32M -9.6% ▼
5Y CAGR: -0.1%
Total Liabilities
$18M +58.4% ▲
5Y CAGR: +21.1%
Shareholders Equity
$15M -40.0% ▼
5Y CAGR: -10.3%
Cash & Investments
$845K +102.9% ▲
5Y CAGR: -16.5%
Total Debt
$5M +5.3% ▲
5Y CAGR: -1.7%
Net Debt
$4M -4.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$8M$2M$416K$845K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$8M$2M$416K$845K
Net Receivables$2M$2M$1M$1M$3M
Inventory$0$339K$879K$1M$1M
Other Current Assets$0$0$571K$346K$417K
Total Current Assets$4M$11M$6M$4M$5M
Property, Plant & Equip.$3M$9M$8M$7M$7M
Goodwill & Intangibles$27M$42M$27M$24M$20M
Long-Term Investments$288K$693K$0$0$0
Other Non-Current Assets$671K$693K$0$0$0
Total Non-Current Assets$31M$51M$35M$31M$27M
Total Assets$35M$62M$41M$36M$32M
— Liabilities —
Accounts Payable$884K$1M$2M$4M$3M
Short-Term Debt$612K$5M$9M$2M$3M
Deferred Revenue$39K$39K$37K$35K$0
Other Current Liabilities$384K$1M$2M$1M$8M
Total Current Liabilities$3M$8M$14M$8M$15M
Long-Term Debt$952K$6M$1M$65K$2M
Other Non-Current Liab.$0$2M$1M$1M$0
Total Non-Current Liabilities$3M$10M$5M$3M$3M
Total Liabilities$6M$18M$19M$11M$18M
— Equity —
Common Stock$23K$27K$3K$16K$19K
Retained Earnings-$17M-$21M-$54M-$67M-$83M
Accumulated OCI$1M$10M$10M-$357K$1M
Total Stockholders Equity$30M$44M$22M$25M$15M
Total Liabilities & Equity$35M$62M$41M$36M$32M
— Key Metrics —
Total Debt$4M$14M$13M$4M$5M
Net Debt$2M$5M$11M$4M$4M
Total Investments$288K$693K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms